Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles
Cristiana Maria Grapa,1,* Teodora Mocan,1,2,* Diana Gonciar,1,3,* Claudiu Zdrehus,1,3,* Ofelia Mosteanu,1,3,* Teodora Pop,1,* Lucian Mocan1,3,* 1Nanomedicine Department, Regional Institute of Gastroenterology and Hepatology “Prof. Dr. Octavian Fodor”, Cluj-Napoca, Romania; 2Physi...
Guardado en:
Autores principales: | Grapa CM, Mocan T, Gonciar D, Zdrehus C, Mosteanu O, Pop T, Mocan L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f8a3b047a084c8f9ddbf344801204d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Laser thermal ablation of multidrug-resistant bacteria using functionalized gold nanoparticles
por: Mocan L, et al.
Publicado: (2017) -
Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy
por: Jorge A. Roacho-Pérez, et al.
Publicado: (2021) -
Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology
por: Alin Mihai Vasilescu, et al.
Publicado: (2021) -
ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli,Meysam, et al.
Publicado: (2019) -
Emodin-Conjugated PEGylation of Fe3O4 Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
por: Ren S, et al.
Publicado: (2021)